Qualitative Analysis of Interviews Between Pharmacist and Elderly Patients Treated with Antithrombotics for an Ischemic Stroke.
NCT05741593 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2024-11-18
Summary
Cerebrovascular accident is the 2nd leading cause of death and the leading cause of disability in the world. There are brakes and levers of medication adherence in the context of secondary prevention treatment in stroke.
Conditions
Interventions
- OTHER
-
Analysis of the verbatim from the transcription of the recorded interviews.
recorded semi-structured interviews between the patients and the pharmacist
Sponsors & Collaborators
-
Hospices Civils de Lyon
lead OTHER
Eligibility
- Min Age
- 65 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-04-01
- Primary Completion
- 2026-04-01
- Completion
- 2026-04-01
Countries
- France
Study Locations
More Related Trials
-
Prescription and Persistence of Antithrombotic Agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients With MCA(Middle Cerebral Artery) Disease
NCT02953405 ·Status: UNKNOWN
-
Study of the Follow-up of Stroke Treated With Anticoagulants
NCT03292575 ·Status: COMPLETED
-
The Prevalence and Associated Factors of Early Deterioration After Successful Recanalization in Acute Ischemic Stroke
NCT04978181 ·Status: UNKNOWN
-
Standard Medical Management in Secondary Prevention of Ischemic Stroke in China
NCT00664846 ·Status: COMPLETED ·Phase: NA
-
Antithrombotic Therapy With Regulation of Blood Pressure in Non-Cardioembolic Progressive Stroke
NCT06551727 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds
NCT05032053 ·Status: RECRUITING
-
A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke
NCT05515393 ·Status: UNKNOWN ·Phase: PHASE2
-
The Effects of Disease Management Programs for Prevention of Recurrent Ischemic Stroke
NCT02121327 ·Status: COMPLETED ·Phase: NA
-
Thrombolysis Combined With Edaravone Dexborneol on Hemorrhagic Transformation for Acute Ischemic Stroke
NCT05035953 ·Status: UNKNOWN ·Phase: PHASE2
-
Long-Term Survival After Ischaemic Stroke: Ebrictus Study
NCT03247036 ·Status: COMPLETED
-
Antiplatelet Therapy and Endothelial-stabilizing Agents in Cerebral Small Vessel Diseases
NCT06715007 ·Status: RECRUITING
-
Midodrine for Ischemic Stroke With Penumbra
NCT02383121 ·Status: WITHDRAWN
-
Observational Study of Efficiency of Cytoflavin, in Patients With Ischemic Stroke Not Receiving Reperfusion Therapy
NCT06514976 ·Status: RECRUITING
-
Mildronate for Acute Ischemic Stroke
NCT01831011 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke
NCT05953480 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Mildronate for Acute Ischemic Stroke
NCT01800357 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke
NCT00790920 ·Status: COMPLETED ·Phase: PHASE3
-
The Impact of NBP on the Collateral Circulation in ICA/M1 Occlusion
NCT02594995 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Pharmacokinetics of MCI-186 in Subjects With Acute Ischemic Stroke
NCT00821821 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Levofloxacin Combined With Intravenous Thrombolysis for Acute Ischemic Stroke
NCT05741905 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy Study in Acute Ischaemic Stroke
NCT00144014 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the KPCXM18 Injection for Treatment of Acute Ischemic Stroke
NCT05745311 ·Status: UNKNOWN ·Phase: PHASE2
-
Statins Role in Acute Ischemic Stroke
NCT06371495 ·Status: NOT_YET_RECRUITING
-
Intra-Arterial Thrombolysis After SUCCESSful Reperfusion in Anterior Circulation Ischemic Stroke
NCT06768138 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of Early Initiation of Butylphthalide Treatment in Patients With Acute Ischemic Stroke.
NCT06472921 ·Status: COMPLETED ·Phase: PHASE2